CollPlant Biotechnologies (CLGN) Asset Utilization Ratio (2018 - 2025)
CollPlant Biotechnologies (CLGN) posted Asset Utilization Ratio of 0.19 for Q4 2025, up 21.42% on a QoQ basis from 0.16 in Q3 2025, and up 246.72% year-over-year from 0.05 in Q4 2024.
CollPlant Biotechnologies (CLGN) Asset Utilization Ratio (2018 - 2025) Analysis & Trends
CollPlant Biotechnologies' Asset Utilization Ratio history runs 8 years deep, the most recent figure standing at 0.19 for Q4 2025.
- Quarterly Asset Utilization Ratio rose 246.72% year-over-year to 0.19 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.19 (up 246.72% YoY) and the FY2025 annual result came in at 0.16, up 724.72% from the prior year.
- Asset Utilization Ratio was 0.19 for Q4 2025 at CollPlant Biotechnologies, up from 0.16 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 3233.58 in Q2 2024 and bottomed at 0.01 in Q4 2022.
- A 5-year average of 608.45 and a median of 0.28 in 2023 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2023 — Asset Utilization Ratio soared 18160145.53% — and 2024, when it sank 100.0%.
- CollPlant Biotechnologies' Asset Utilization Ratio stood at 0.3 in 2021, then plunged by 95.35% to 0.01 in 2022, then surged by 18160145.53% to 2517.94 in 2023, then sank by 100.0% to 0.05 in 2024, then surged by 246.72% to 0.19 in 2025.
- Business Quant data shows CLGN's Asset Utilization Ratio at 0.19 in Q4 2025, 0.16 in Q3 2025, and 0.05 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 0.69 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.19 |
| Sep 30, 2025 | 0.16 |
| Dec 31, 2024 | 0.05 |
| Sep 30, 2024 | 0.05 |
| Jun 30, 2024 | 3,233.58 |
| Mar 31, 2024 | 2,518.46 |
| Dec 31, 2023 | 2,517.94 |
| Sep 30, 2023 | 2,067.49 |
| Jun 30, 2023 | 0.28 |
| Mar 31, 2023 | 0.02 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.03 |
| Dec 31, 2021 | 0.30 |
| Sep 30, 2021 | 0.40 |
| Jun 30, 2021 | 0.77 |
| Mar 31, 2021 | 3.94 |
| Dec 31, 2020 | 0.64 |
| Sep 30, 2020 | 0.16 |
| Jun 30, 2020 | 0.21 |